Fluoroquinolone-Associated Tendinopathy: A Critical Review of the Literature
Related Articles
- Tendon rupture linked to antibiotic. // Drug Topics;2/6/95, Vol. 139 Issue 3, p8
Reports that tendon rupture has been linked to fluoroquinolone antibiotics. Revision of labeling; Number of cases reported.
- Gemifloxacin: A broad-spectrum oral quinolone for treatment of respiratory and urinary tract infections. Lomaestro, Ben M. // Formulary;Dec2000, Vol. 35 Issue 12, p961
Examines the pharmacokinetic and pharmacodynamic characteristics of gemifloxacin, a potent fluoroquinolone, against several pathogens. Use of gemifloxacin in the treatment of respiratory and urinary tract infections; Drug interactions; Adverse effect profile.
- Ciprofloxacin and Achilles’ tendon rupture: a causal relationship. Ozaras, Resat; Mert, Ali; Tahan, Veysel; Uraz, Suleyman; Ozaydin, Ismet; Yilmaz, Mehmet Halit; Ozaras, Nihal // Clinical Rheumatology;Dec2003, Vol. 22 Issue 6, p500
This article describes a case of spontaneous rupture of the Achilles' tendon associated with ciprofloxacin use on one side, and the development of the same complication on the other side 1 year later following another use of the same drug. A 32-year-old male surgeon presented with a severe pain...
- Atemnot und Gehunfähigkeit. Schuster, Stefanie; Diethelm, Markus // Praxis (16618157);7/3/2013, Vol. 102 Issue 14, p873
We report the case of a 73 year old patient with a COPD. A severe exazerbation was treated with glucocorticoids and Quinolones. A few days later both ankles were tender and painful. Ultrasound examination showed bilateral Achilles tendon ruptures. Diagnostics, etiology and therapeutic options...
- Four consecutive cases of Achilles tendon disorders associated with levofloxacin treatment in hemodialysis patients. Takeda, Shin-ichi; Imai, Toshimi; Chaki, Yuko; Kusano, Eiji // Clinical & Experimental Nephrology;Dec2012, Vol. 16 Issue 6, p977
No abstract available.
- Clinical Perspectives on New Antimicrobials: Focus on Fluoroquinolones. Talan, David A. // Clinical Infectious Diseases;3/15/2001 Supplement 1, Vol. 32, pS64
Respiratory tract infections are the most common infectious presentation in the community and hospital settings and are a major cause of morbidity and mortality worldwide. Recently, newer fluoroquinolones have been recommended for the treatment of these infections. Among them, moxifloxacin shows...
- New fluoroquinolone has dual activity against resistant bugs. LoBuono, Charlotte // Drug Topics;5/5/2003, Vol. 147 Issue 9, p16
Reports on the U.S. Food and Drug Administration's approval of gemifloxacin for the treatment of acute exacerbations of chronic bronchitis. Fourth-generation fluoroquinolone with dual activity against bacteria to treat community-acquired respiratory infections; Inhibition of DNA synthesis...
- Antibiotic Use Declines Overall, While Use of Broad-Spectrum Increases. // Clinical Oncology Alert;Oct2009 Supplement, p1
The article reports on a decline in antibiotics use for the treatment of acute respiratory tract infections (ARTI) based on data obtained between 1995 and 2006. Antibiotics trends were examined using a national database for ARTI. It showed that children below the age of 5 were less likely to be...
- Antibiotic Use Declines Overall, While Use of Broad-Spectrum Increases. Elliott, William T. // Neurology Alert;Oct2010 Primary Care, p1
The article discusses a study which examines the use of antibiotics for acute respiratory tract infections (ARTIs). Conducted from 1995 to 2006, the study found that children under 5 years old were seen less frequently to experience ARTI compared from the past. The study also revealed that the...